- Report
- January 2026
- 182 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- January 2026
- 182 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- January 2026
- 194 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- January 2026
- 189 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- August 2025
- 188 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- August 2025
- 195 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- August 2025
- 189 Pages
Global
From €3209EUR$3,545USD£2,749GBP
€3566EUR$3,939USD£3,055GBP
- Report
- May 2026
- 180 Pages
Global
From €4073EUR$4,500USD£3,490GBP
- Report
- January 2026
- 105 Pages
Global
From €4300EUR$4,750USD£3,684GBP
- Report
- April 2026
- 160 Pages
Global
From €3005EUR$3,320USD£2,575GBP
€3757EUR$4,150USD£3,218GBP
- Report
- April 2026
- 160 Pages
Global
From €3005EUR$3,320USD£2,575GBP
€3757EUR$4,150USD£3,218GBP
- Report
- April 2026
- 160 Pages
Global
From €3005EUR$3,320USD£2,575GBP
€3757EUR$4,150USD£3,218GBP
- Report
- November 2025
- 160 Pages
Global
From €2860EUR$3,160USD£2,451GBP
€3576EUR$3,950USD£3,063GBP
- Report
- October 2025
- 160 Pages
Global
From €2860EUR$3,160USD£2,451GBP
€3576EUR$3,950USD£3,063GBP
- Report
- May 2026
- 140 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- February 2026
- 213 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- September 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- August 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Newsletter
- July 2026
Global
€2711EUR$2,995USD£2,323GBP
- Report
- March 2026
- 249 Pages
United States
From €4390EUR$4,850USD£3,761GBP

Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments.
The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated.
Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more